{
    "info": {
        "nct_id": "NCT03895203",
        "official_title": "A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Active Reference (Adalimumab) Study Evaluating the Efficacy and Safety of Bimekizumab in the Treatment of Subjects With Active Psoriatic Arthritis",
        "inclusion_criteria": "* An Institutional Review Board (IRB)/Independent Ethics Committee (IEC) approved written Informed Consent form is signed and dated by the subject\n* Subject is male or female at least 18 years of age\n* Female subject must be postmenopausal, permanently sterilized or willing to use a highly effective method of contraception\n* Documented diagnosis of adult-onset Psoriatic Arthritis (PsA) meeting the Classification Criteria for Psoriatic Arthritis (CASPAR) for at least 6 months prior to Screening with active PsA and must have at Baseline tender joint count (TJC) >=3 out of 68 and swollen joint count (SJC) >=3 out of 66\n* Subject must be negative for rheumatoid factor and anti-cyclic citrullinated peptide (CCP) antibodies\n* Subject must have at least 1 active psoriatic lesion(s) and/or a documented history of psoriasis (PSO)\n* Subject must be a suitable candidate for treatment with adalimumab and has no contraindications to receive adalimumab as per the local label as assessed by the Investigator\n* Subjects currently taking NSAIDs, cyclooxygenase 2 (COX-2) inhibitors, analgesics (including mild opioids), corticosteroids, methotrexate (MTX), leflunomide (LEF), sulfasalazine (SSZ), hydroxychloroquine (HCQ) AND/OR apremilast can be allowed if they fulfill specific requirements prior to study entry\nHealthy volunteers allowed\nMust have minimum age of 18 Years",
        "exclusion_criteria": "* Female subjects who are breastfeeding, pregnant, or plan to become pregnant during the study\n* Subjects with current or prior exposure to any biologics for the treatment of Psoriatic Arthritis (PsA) or Psoriasis (PSO)\n* Subject has an active infection or a history of recent serious infections\n* Subject has known tuberculosis (TB) infection, is at high risk of acquiring TB infection, or has current or history of nontuberculous mycobacterium (NTMB) infection\n* Subject has a diagnosis of inflammatory conditions other than PSO or PsA. Subjects with a diagnosis of Crohn's disease, ulcerative colitis, or other inflammatory bowel disease (IBD) are allowed as long as they have no active symptomatic disease at Screening or Baseline\n* Subject had acute anterior uveitis within 6 weeks of Baseline\n* Subject has any active malignancy or history of malignancy within 5 years prior to the Screening Visit EXCEPT treated and considered cured cutaneous squamous or basal cell carcinoma, or in situ cervical cancer\n* Subject has a form of PSO other than chronic plaque-type (eg, pustular, erythrodermic and guttate PSO, or drug-induced PSO)\n* Presence of active suicidal ideation, or moderately severe major depression or severe major depression\n* Subject has a history of chronic alcohol or drug abuse within 6 months prior to Screening",
        "miscellaneous_criteria": ""
    },
    "inclusion_lines": [
        {
            "line": "* Subject is male or female at least 18 years of age",
            "criterions": [
                {
                    "exact_snippets": "Subject is male or female",
                    "criterion": "sex",
                    "requirements": [
                        {
                            "requirement_type": "allowed_values",
                            "expected_value": [
                                "male",
                                "female"
                            ]
                        }
                    ]
                },
                {
                    "exact_snippets": "at least 18 years of age",
                    "criterion": "age",
                    "requirements": [
                        {
                            "requirement_type": "minimum",
                            "expected_value": {
                                "operator": ">=",
                                "value": 18,
                                "unit": "years"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Female subject must be postmenopausal, permanently sterilized or willing to use a highly effective method of contraception",
            "criterions": [
                {
                    "exact_snippets": "Female subject",
                    "criterion": "sex",
                    "requirements": [
                        {
                            "requirement_type": "value",
                            "expected_value": "female"
                        }
                    ]
                },
                {
                    "exact_snippets": "postmenopausal",
                    "criterion": "menopausal status",
                    "requirements": [
                        {
                            "requirement_type": "status",
                            "expected_value": "postmenopausal"
                        }
                    ]
                },
                {
                    "exact_snippets": "permanently sterilized",
                    "criterion": "sterilization status",
                    "requirements": [
                        {
                            "requirement_type": "status",
                            "expected_value": "permanently sterilized"
                        }
                    ]
                },
                {
                    "exact_snippets": "willing to use a highly effective method of contraception",
                    "criterion": "contraception use",
                    "requirements": [
                        {
                            "requirement_type": "willingness to use",
                            "expected_value": "highly effective method of contraception"
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Subject must be negative for rheumatoid factor and anti-cyclic citrullinated peptide (CCP) antibodies",
            "criterions": [
                {
                    "exact_snippets": "negative for rheumatoid factor",
                    "criterion": "rheumatoid factor",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": false
                        }
                    ]
                },
                {
                    "exact_snippets": "negative for ... anti-cyclic citrullinated peptide (CCP) antibodies",
                    "criterion": "anti-cyclic citrullinated peptide (CCP) antibodies",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": false
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Documented diagnosis of adult-onset Psoriatic Arthritis (PsA) meeting the Classification Criteria for Psoriatic Arthritis (CASPAR) for at least 6 months prior to Screening with active PsA and must have at Baseline tender joint count (TJC) >=3 out of 68 and swollen joint count (SJC) >=3 out of 66",
            "criterions": [
                {
                    "exact_snippets": "Documented diagnosis of adult-onset Psoriatic Arthritis (PsA)",
                    "criterion": "Psoriatic Arthritis diagnosis",
                    "requirements": [
                        {
                            "requirement_type": "diagnosis",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "onset age group",
                            "expected_value": "adult"
                        }
                    ]
                },
                {
                    "exact_snippets": "meeting the Classification Criteria for Psoriatic Arthritis (CASPAR)",
                    "criterion": "CASPAR criteria for Psoriatic Arthritis",
                    "requirements": [
                        {
                            "requirement_type": "meets criteria",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "for at least 6 months prior to Screening",
                    "criterion": "duration of Psoriatic Arthritis diagnosis",
                    "requirements": [
                        {
                            "requirement_type": "duration",
                            "expected_value": {
                                "operator": ">=",
                                "value": 6,
                                "unit": "months"
                            }
                        }
                    ]
                },
                {
                    "exact_snippets": "with active PsA",
                    "criterion": "active Psoriatic Arthritis",
                    "requirements": [
                        {
                            "requirement_type": "disease activity",
                            "expected_value": "active"
                        }
                    ]
                },
                {
                    "exact_snippets": "at Baseline tender joint count (TJC) >=3 out of 68",
                    "criterion": "tender joint count (TJC) at Baseline",
                    "requirements": [
                        {
                            "requirement_type": "count",
                            "expected_value": {
                                "operator": ">=",
                                "value": 3,
                                "unit": "joints"
                            }
                        }
                    ]
                },
                {
                    "exact_snippets": "swollen joint count (SJC) >=3 out of 66",
                    "criterion": "swollen joint count (SJC) at Baseline",
                    "requirements": [
                        {
                            "requirement_type": "count",
                            "expected_value": {
                                "operator": ">=",
                                "value": 3,
                                "unit": "joints"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Subject must have at least 1 active psoriatic lesion(s) and/or a documented history of psoriasis (PSO)",
            "criterions": [
                {
                    "exact_snippets": "at least 1 active psoriatic lesion(s)",
                    "criterion": "active psoriatic lesions",
                    "requirements": [
                        {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": ">=",
                                "value": 1,
                                "unit": "lesion"
                            }
                        },
                        {
                            "requirement_type": "activity",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "documented history of psoriasis (PSO)",
                    "criterion": "history of psoriasis",
                    "requirements": [
                        {
                            "requirement_type": "history",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "documentation",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Subject must be a suitable candidate for treatment with adalimumab and has no contraindications to receive adalimumab as per the local label as assessed by the Investigator",
            "criterions": [
                {
                    "exact_snippets": "Subject must be a suitable candidate for treatment with adalimumab",
                    "criterion": "suitability for adalimumab treatment",
                    "requirements": [
                        {
                            "requirement_type": "suitability",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "has no contraindications to receive adalimumab as per the local label as assessed by the Investigator",
                    "criterion": "contraindications to adalimumab",
                    "requirements": [
                        {
                            "requirement_type": "absence",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "Healthy volunteers allowed",
            "criterions": [
                {
                    "exact_snippets": "Healthy volunteers allowed",
                    "criterion": "healthy volunteer status",
                    "requirements": [
                        {
                            "requirement_type": "eligibility",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Subjects currently taking NSAIDs, cyclooxygenase 2 (COX-2) inhibitors, analgesics (including mild opioids), corticosteroids, methotrexate (MTX), leflunomide (LEF), sulfasalazine (SSZ), hydroxychloroquine (HCQ) AND/OR apremilast can be allowed if they fulfill specific requirements prior to study entry",
            "criterions": [
                {
                    "exact_snippets": "Subjects currently taking NSAIDs",
                    "criterion": "NSAID use",
                    "requirements": [
                        {
                            "requirement_type": "current use",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "cyclooxygenase 2 (COX-2) inhibitors",
                    "criterion": "COX-2 inhibitor use",
                    "requirements": [
                        {
                            "requirement_type": "current use",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "analgesics (including mild opioids)",
                    "criterion": "analgesic use",
                    "requirements": [
                        {
                            "requirement_type": "current use",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "corticosteroids",
                    "criterion": "corticosteroid use",
                    "requirements": [
                        {
                            "requirement_type": "current use",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "methotrexate (MTX)",
                    "criterion": "methotrexate use",
                    "requirements": [
                        {
                            "requirement_type": "current use",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "leflunomide (LEF)",
                    "criterion": "leflunomide use",
                    "requirements": [
                        {
                            "requirement_type": "current use",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "sulfasalazine (SSZ)",
                    "criterion": "sulfasalazine use",
                    "requirements": [
                        {
                            "requirement_type": "current use",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "hydroxychloroquine (HCQ)",
                    "criterion": "hydroxychloroquine use",
                    "requirements": [
                        {
                            "requirement_type": "current use",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "apremilast",
                    "criterion": "apremilast use",
                    "requirements": [
                        {
                            "requirement_type": "current use",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "Must have minimum age of 18 Years",
            "criterions": [
                {
                    "exact_snippets": "minimum age of 18 Years",
                    "criterion": "age",
                    "requirements": [
                        {
                            "requirement_type": "minimum",
                            "expected_value": {
                                "operator": ">=",
                                "value": 18,
                                "unit": "years"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "* An Institutional Review Board (IRB)/Independent Ethics Committee (IEC) approved written Informed Consent form is signed and dated by the subject",
            "criterions": [
                {
                    "exact_snippets": "An Institutional Review Board (IRB)/Independent Ethics Committee (IEC) approved written Informed Consent form is signed and dated by the subject",
                    "criterion": "informed consent form",
                    "requirements": [
                        {
                            "requirement_type": "approval",
                            "expected_value": "IRB/IEC approved"
                        },
                        {
                            "requirement_type": "format",
                            "expected_value": "written"
                        },
                        {
                            "requirement_type": "signature",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "date",
                            "expected_value": true
                        }
                    ]
                }
            ]
        }
    ],
    "exclusion_lines": [
        {
            "line": "* Subject has a diagnosis of inflammatory conditions other than PSO or PsA. Subjects with a diagnosis of Crohn's disease, ulcerative colitis, or other inflammatory bowel disease (IBD) are allowed as long as they have no active symptomatic disease at Screening or Baseline",
            "criterions": [
                {
                    "exact_snippets": "diagnosis of inflammatory conditions other than PSO or PsA",
                    "criterion": "inflammatory conditions (excluding PSO or PsA)",
                    "requirements": [
                        {
                            "requirement_type": "diagnosis",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "diagnosis of Crohn's disease, ulcerative colitis, or other inflammatory bowel disease (IBD) ... no active symptomatic disease at Screening or Baseline",
                    "criterion": "Crohn's disease, ulcerative colitis, or other IBD",
                    "requirements": [
                        {
                            "requirement_type": "diagnosis",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "active symptomatic disease at Screening or Baseline",
                            "expected_value": false
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Subject has known tuberculosis (TB) infection, is at high risk of acquiring TB infection, or has current or history of nontuberculous mycobacterium (NTMB) infection",
            "criterions": [
                {
                    "exact_snippets": "Subject has known tuberculosis (TB) infection",
                    "criterion": "tuberculosis (TB) infection",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "is at high risk of acquiring TB infection",
                    "criterion": "risk of acquiring tuberculosis (TB) infection",
                    "requirements": [
                        {
                            "requirement_type": "risk level",
                            "expected_value": "high"
                        }
                    ]
                },
                {
                    "exact_snippets": "has current or history of nontuberculous mycobacterium (NTMB) infection",
                    "criterion": "nontuberculous mycobacterium (NTMB) infection",
                    "requirements": [
                        {
                            "requirement_type": "current presence",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "history",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Subject has a form of PSO other than chronic plaque-type (eg, pustular, erythrodermic and guttate PSO, or drug-induced PSO)",
            "criterions": [
                {
                    "exact_snippets": "Subject has a form of PSO other than chronic plaque-type (eg, pustular, erythrodermic and guttate PSO, or drug-induced PSO)",
                    "criterion": "psoriasis type",
                    "requirements": [
                        {
                            "requirement_type": "type",
                            "expected_value": [
                                "pustular",
                                "erythrodermic",
                                "guttate",
                                "drug-induced"
                            ]
                        },
                        {
                            "requirement_type": "exclusion",
                            "expected_value": "chronic plaque-type"
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Subject had acute anterior uveitis within 6 weeks of Baseline",
            "criterions": [
                {
                    "exact_snippets": "acute anterior uveitis within 6 weeks of Baseline",
                    "criterion": "acute anterior uveitis",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "timeframe",
                            "expected_value": {
                                "operator": "<=",
                                "value": 6,
                                "unit": "weeks from Baseline"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Subject has a history of chronic alcohol or drug abuse within 6 months prior to Screening",
            "criterions": [
                {
                    "exact_snippets": "history of chronic alcohol ... within 6 months prior to Screening",
                    "criterion": "chronic alcohol abuse",
                    "requirements": [
                        {
                            "requirement_type": "history_within_timeframe",
                            "expected_value": {
                                "operator": "<=",
                                "value": 6,
                                "unit": "months prior to Screening"
                            }
                        }
                    ]
                },
                {
                    "exact_snippets": "history of chronic ... drug abuse within 6 months prior to Screening",
                    "criterion": "chronic drug abuse",
                    "requirements": [
                        {
                            "requirement_type": "history_within_timeframe",
                            "expected_value": {
                                "operator": "<=",
                                "value": 6,
                                "unit": "months prior to Screening"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Subject has any active malignancy or history of malignancy within 5 years prior to the Screening Visit EXCEPT treated and considered cured cutaneous squamous or basal cell carcinoma, or in situ cervical cancer",
            "criterions": [
                {
                    "exact_snippets": "Subject has any active malignancy",
                    "criterion": "active malignancy",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": false
                        }
                    ]
                },
                {
                    "exact_snippets": "history of malignancy within 5 years prior to the Screening Visit",
                    "criterion": "history of malignancy",
                    "requirements": [
                        {
                            "requirement_type": "time since malignancy",
                            "expected_value": {
                                "operator": "<=",
                                "value": 5,
                                "unit": "years"
                            }
                        },
                        {
                            "requirement_type": "presence",
                            "expected_value": false
                        }
                    ]
                },
                {
                    "exact_snippets": "EXCEPT treated and considered cured cutaneous squamous or basal cell carcinoma, or in situ cervical cancer",
                    "criterion": "history of cutaneous squamous or basal cell carcinoma, or in situ cervical cancer",
                    "requirements": [
                        {
                            "requirement_type": "treatment and cure status",
                            "expected_value": "treated and considered cured"
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Presence of active suicidal ideation, or moderately severe major depression or severe major depression",
            "criterions": [
                {
                    "exact_snippets": "Presence of active suicidal ideation",
                    "criterion": "active suicidal ideation",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "moderately severe major depression",
                    "criterion": "major depression",
                    "requirements": [
                        {
                            "requirement_type": "severity",
                            "expected_value": "moderately severe"
                        }
                    ]
                },
                {
                    "exact_snippets": "severe major depression",
                    "criterion": "major depression",
                    "requirements": [
                        {
                            "requirement_type": "severity",
                            "expected_value": "severe"
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Subjects with current or prior exposure to any biologics for the treatment of Psoriatic Arthritis (PsA) or Psoriasis (PSO)",
            "criterions": [
                {
                    "exact_snippets": "current or prior exposure to any biologics for the treatment of Psoriatic Arthritis (PsA) or Psoriasis (PSO)",
                    "criterion": "exposure to biologics for Psoriatic Arthritis or Psoriasis",
                    "requirements": [
                        {
                            "requirement_type": "exposure_status",
                            "expected_value": [
                                "current",
                                "prior"
                            ]
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Female subjects who are breastfeeding, pregnant, or plan to become pregnant during the study",
            "criterions": [
                {
                    "exact_snippets": "Female subjects who are breastfeeding",
                    "criterion": "breastfeeding status",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "pregnant",
                    "criterion": "pregnancy status",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "plan to become pregnant during the study",
                    "criterion": "pregnancy intention during the study",
                    "requirements": [
                        {
                            "requirement_type": "intention",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Subject has an active infection or a history of recent serious infections",
            "criterions": [
                {
                    "exact_snippets": "Subject has an active infection",
                    "criterion": "active infection",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "history of recent serious infections",
                    "criterion": "recent serious infections",
                    "requirements": [
                        {
                            "requirement_type": "history",
                            "expected_value": true
                        }
                    ]
                }
            ]
        }
    ],
    "miscellaneous_lines": [],
    "failed_inclusion": [],
    "failed_exclusion": [],
    "failed_miscellaneous": []
}